Annual FCF
-$28.82 M
NaN%
December 31, 2023
Summary
- As of February 12, 2025, RAPP annual free cash flow is -$28.82 million
- RAPP annual FCF is now at all-time high.
Performance
RAPP Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$16.55 M
+$764.00 K+4.41%
September 30, 2024
Summary
- As of February 12, 2025, RAPP quarterly free cash flow is -$16.55 million, with the most recent change of +$764.00 thousand (+4.41%) on September 30, 2024.
- Over the past year, RAPP quarterly FCF has increased by +$2.13 million (+11.41%).
- RAPP quarterly FCF is now -240.50% below its all-time high of -$4.86 million, reached on March 31, 2023.
Performance
RAPP Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$64.36 M
-$11.08 M-20.80%
September 30, 2024
Summary
- As of February 12, 2025, RAPP TTM free cash flow is -$64.36 million, with the most recent change of -$11.08 million (-20.80%) on September 30, 2024.
- Over the past year, RAPP TTM FCF has dropped by -$21.71 million (-50.92%).
- RAPP TTM FCF is now -1223.63% below its all-time high of -$4.86 million, reached on March 31, 2023.
Performance
RAPP TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
RAPP Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +11.4% | -50.9% |
| 3 y3 years | - | -240.5% | -1223.6% |
| 5 y5 years | - | -240.5% | -1223.6% |
RAPP Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -240.5% | +11.4% | -1223.6% | at low |
| 5 y | 5-year | at high | at low | -240.5% | +11.4% | -1223.6% | at low |
| alltime | all time | at high | at low | -240.5% | +11.4% | -1223.6% | at low |
Rapport Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$16.55 M(-4.4%) | -$64.36 M(+20.8%) |
| Jun 2024 | - | -$17.32 M(-7.3%) | -$53.28 M(+24.9%) |
| Mar 2024 | - | -$18.69 M(+58.4%) | -$42.64 M(+48.0%) |
| Dec 2023 | -$28.82 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | - | -$11.79 M(+115.4%) | -$28.82 M(+69.3%) |
| Sep 2023 | - | -$5.48 M(-18.1%) | -$17.02 M(+47.4%) |
| Jun 2023 | - | -$6.68 M(+37.5%) | -$11.55 M(+137.5%) |
| Mar 2023 | - | -$4.86 M | -$4.86 M |
FAQ
- What is Rapport Therapeutics annual free cash flow?
- What is the all time high annual FCF for Rapport Therapeutics?
- What is Rapport Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Rapport Therapeutics?
- What is Rapport Therapeutics quarterly FCF year-on-year change?
- What is Rapport Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Rapport Therapeutics?
- What is Rapport Therapeutics TTM FCF year-on-year change?
What is Rapport Therapeutics annual free cash flow?
The current annual FCF of RAPP is -$28.82 M
What is the all time high annual FCF for Rapport Therapeutics?
Rapport Therapeutics all-time high annual free cash flow is -$28.82 M
What is Rapport Therapeutics quarterly free cash flow?
The current quarterly FCF of RAPP is -$16.55 M
What is the all time high quarterly FCF for Rapport Therapeutics?
Rapport Therapeutics all-time high quarterly free cash flow is -$4.86 M
What is Rapport Therapeutics quarterly FCF year-on-year change?
Over the past year, RAPP quarterly free cash flow has changed by +$2.13 M (+11.41%)
What is Rapport Therapeutics TTM free cash flow?
The current TTM FCF of RAPP is -$64.36 M
What is the all time high TTM FCF for Rapport Therapeutics?
Rapport Therapeutics all-time high TTM free cash flow is -$4.86 M
What is Rapport Therapeutics TTM FCF year-on-year change?
Over the past year, RAPP TTM free cash flow has changed by -$21.71 M (-50.92%)